A prospective, observational, multicentre study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI (STEPP - AMI)

Open Heart

Volumn 1, Issue 1, 2014, Pages

  Victor, Suma M ^a   Subban, Vijayakumar ^a   Alexander, Thomas ^b   Bahuleyan, C G ^c   Srinivas, Arun ^d   Selvamani, S ^e   Mullasari, Ajit S ^a  

^a MADRAS MEDICAL MISSION HOSPITAL   (India)

^b Kovai Medical Center and Hospital   (India)

^c Ananthapuri Hospitals and Research Institute   (India)

^d Vikram Hospital   (India)

^e MEENAKSHI MISSION HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TENECTEPLASE;

ADULT; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DEATH; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART REINFARCTION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PILOT STUDY; PROSPECTIVE STUDY; REPEAT PROCEDURE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VASCULAR PATENCY;

EID: 84984619770     PISSN: None     EISSN: 20533624     Source Type: Journal    
DOI: 10.1136/openhrt-2014-000133     Document Type: Article

References (14)

1. Steg PG, James SK, Atar D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619.
2. Stone GW. Angioplasty strategies in ST-segment-elevation myocardial infarction. Part I: primary percutaneous coronary intervention. Circulation 2008;118:538-51.
3. Iyengar SS, Nair T, Sathyamurthi I, et al. Efficacy and safety of tenecteplase in STEMI patients from ELAXIM Indian registry. Indian Heart J 2009;61:480-1.
4. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42.
5. Armstrong PW, Boden WE. Reperfusion paradox in ST-segment elevation myocardial infarction. Ann Intern Med 2011;155:389-91.
6. Xavier D, Pais P, Devereaux PJ, et al. CREATE registry investigators. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 2008;371:1435-42.
7. Kushner FG, Hand M, Smith SC, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). J Am Coll Cardiol 2009;54:22052241.
8. Pakshirajan B, Subban V, Mullasari AS. Pharmacoinvasive management. Interv Cardiol Clin 2012;1:409-19.
9. Armstrong PW, Gershlick AH, Goldstein P, et al.; for the STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013;368:1379-87.
10. Steg PG, Bonnefoy E, Chabaud S, et al. Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial infarction (CAPTIM) Investigators Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003;108:2851-6.
11. Hanna E, Hennebry TA, Abdu-Fadel MS. Combined reperfusion strategies in ST-segment elevation MI: rationale and current role. Cleve Clin J Med 2010;77:629-38.
12. Kelbæk H, Engstrøm T, Ahtarovski KA, et al. Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study. EuroIntervention 2013;8:1126-33.
13. Van de Werf F, Barron HV, Armstrong PW, et al. Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA. Eur Heart J 2001;22:2253-61.
14. Jolly SS, Yusuf S, Cairns J, et al. Radial vs. femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet 2011;377:1409-20.